Who Pays for Care? The Numbers Behind India's Health Financing

The Macro Funding Gap: Public Allocations vs National Health Policy Targets

Health financing in India remains defined by a persistent structural mismatch between policy commitments and fiscal outlays. An editorial summary published by Drishti IAS on 22 April 2026 synthesized the critical macroeconomic metrics governing India's health expenditure. According to the summary, combined government health spending (incorporating both Union and State budgets) sits at approximately 2% of Gross Domestic Product. While this represents a notable expansion from the 1.2% to 1.4% range recorded a decade ago, it remains conspicuously short of the 2.5% of GDP target explicitly mandated for achievement by 2025 under the National Health Policy 2017.

At the central level, the analysis observed a proportional retrenchment in Union health allocations relative to national economic output. The Union health budget declined from 0.37% of GDP in the pandemic fiscal year 2020-21 (actual expenditure) to 0.29% of GDP in the 2025-26 Budget Estimates. Even as aggregate budgetary allocations expand in nominal rupee terms due to top-line GDP growth, health's claim on the central fiscal envelope has narrowed.

The consequence of this public under-funding is borne directly by Indian families. Out-of-pocket expenditure (OOPE) was estimated at approximately 39% of total health expenditure. While substantially improved from the historical peak exceeding 60% in the mid-2010s, this ratio indicates that nearly four out of every ten rupees expended on medical consultations, diagnostics, surgical packages, and pharmaceuticals still flow straight from private household savings.

On social protection, the summary observed that Ayushman Bharat PM-JAY targets roughly 120 million families (representing the poorest 40% of the population) with annual secondary and tertiary hospitalization cover of Rs 5 lakh per family. By February 2026, 11.69 crore hospital admissions had been officially authorized under the scheme, with private empanelled hospitals accounting for 6.74 crore of that volume. In addition, the summary highlighted a Comptroller and Auditor General (CAG) audit report that flagged an unremitted balance of Rs 43,426 crore in health and education cess collections that had not been transferred to the dedicated non-lapsable health reserve fund (Pradhan Mantri Swasthya Suraksha Nidhi).

Pre-Budget Expectations vs Fiscal Realities: What the Sector Awaits

In parallel with policy reviews, capital market analysts have tracked legislative and budgetary dynamics. A healthcare sector preview issued by brokerage firm Swastika Investmart, dated 10 March 2026—written as a forward-looking analysis of pending fiscal policy—documented industry sentiment surrounding the 2026-27 Union Budget cycle. The preview noted that the preceding year's combined budget for the Ministry of Health and Family Welfare and the Ministry of AYUSH stood between Rs 95,000 crore and Rs 1,00,000 crore, reflecting an annual growth of 9% to 10%.

Industry consensus and institutional analysts anticipated that the enacted 2026-27 allocation would cross Rs 1,00,000 crore to settle between Rs 1.10 lakh crore and Rs 1.15 lakh crore. The Swastika preview compiled a detailed catalog of sector demands rather than statutory enactments. These included extending PM-JAY coverage to outpatient consultations and preventive diagnostic checkups; raising tax deduction thresholds under Section 80D for senior citizen health insurance premiums; creating viability gap funding and direct tax holidays for private hospital chains developing tertiary facilities in Tier-2 and Tier-3 districts; instituting accelerated depreciation allowances on high-technology medical imaging equipment; and rationalizing GST rates into a uniform low tier across medical devices and in vitro diagnostics. Readers must note these items reflect commercial expectations, requiring verification against enacted Finance Acts.

“Coverage is counted in cards; protection is counted in rupees not spent.”

Five Structural Deductions: Deconstructing the Indian Health Financing Model

Synthesizing the figures from the Drishti IAS summary and market analyses yields five essential takeaways regarding India's health financing architecture:

1. The sovereign funding deficit remains substantial. A gap of approximately 0.5% of GDP between actual public outlays (~2.0%) and the National Health Policy target (2.5%) represents an annual fiscal shortfall exceeding Rs 1.5 lakh crore in absolute terms. In the absence of state financing, the private sector and household balance sheets serve as involuntary shock absorbers.

2. Out-of-pocket spending is the ultimate balancing item. At 39% of total expenditure, out-of-pocket healthcare costs represent one of the primary drivers of household debt and downward economic mobility in India. Insurance cards eliminate costs only when the empanelled network is geographically accessible, package tariffs cover complete treatment episodes, and no hidden pharmacy or consumable bills are passed to the patient.

3. Public insurance relies predominantly on private infrastructure. With private facilities executing 6.74 crore out of 11.69 crore authorized PM-JAY admissions (57.6%), the state's flagship protection mechanism is structurally dependent on commercial hospitals. If reimbursement tariffs are fixed below cost, private participation collapses or shifts toward cost-cutting compromises.

4. Earmarked levies face administrative execution friction. The CAG-flagged Rs 43,426 crore gap in cess transfers demonstrates that raising tax revenue through special surcharges does not guarantee programmatic expenditure. Administrative and treasury bottlenecks can choke the flow of resources to capital healthcare projects.

5. Proportional fiscal priority can erode during economic growth. If national nominal GDP expands at 10% to 11% while health allocations grow at 8% to 9%, public health expenditure as a percentage of GDP declines even as nominal budget figures establish record highs. Observers must continuously track both nominal rupees and percentage shares.

Operational Guidance for Hospital Providers: Tariffs, Working Capital and Payer Mix

For executives managing clinical enterprises, nursing homes, and diagnostic chains, India's financing environment mandates clear operational protocols:

• Dissect procedure-level unit economics. Public scheme package rates are not uniform in margin. Certain standard orthopaedic or cardiac packages may yield sustainable margins through surgical volume, whereas complex critical care or oncology protocols may sit below direct variable delivery costs. Providers must calculate fully absorbed unit costs—including staff time, consumables, sterilization, and equipment depreciation—for every major clinical code.

• Build dedicated working capital buffers. Public insurance nodal agencies and third-party administrators (TPAs) routinely take between 45 and 90 days to verify and disburse claims. Smaller hospitals with tight cash reserves risk acute liquidity crises when trying to meet pharmaceutical vendor cycles and monthly payroll. Providers must secure committed revolving credit lines or explore invoice discounting mechanisms tied to approved hospital receivables.

• Eliminate documentation friction to curb denials. A primary source of margin leakage is claim rejection or unilateral deduction by scheme auditors. Establishing strict pre-authorization checklists, real-time clinical documentation protocols, and standardized discharge summaries can cut denial rates from double digits down to under 5%.

• Maintain a resilient payer portfolio. Heavily skewing a facility's bed allocation toward public schemes exposes the business to sudden tariff adjustments or bureaucratic disbursement freezes. Conversely, catering exclusively to self-pay cash patients limits volume. A balanced portfolio across commercial insurance, public schemes, and direct cash provides operational stability.

• Position for preventive and ambulatory shifts. If state policy expands to encompass outpatient diagnostics and chronic disease management, providers possessing cost-effective ambulatory clinics and primary diagnostic hubs will capture steady patient flow.

Implications for Families, Omitted Indicators and the Long-Term Policy Question

For Indian families navigating medical contingencies, coverage under a policy or scheme is not an absolute financial guarantee. Households must carefully scrutinize insurance exclusions, pre-existing disease waiting periods, room-rent sub-limits, and co-payment clauses. When utilizing public entitlements such as PM-JAY, beneficiaries should verify active empanelment directly through government portals before admission to avoid unexpected out-of-pocket billing for consumables.

What current published sources fail to disclose is as revealing as the figures provided. Official and secondary summaries consistently omit systemic claim rejection percentages, average out-of-pocket expenditure incurred by beneficiaries during ostensibly cashless admissions, and regional wait times for high-demand surgical interventions. Without these operational metrics, measuring the true efficacy of financial risk protection remains incomplete.

For policymakers, the defining test of India's health financing over the next decade is whether aggregate insurance expansion actually curtails catastrophic medical spending among the bottom four income deciles. Tracking longitudinal out-of-pocket expenditure by socioeconomic cohort is the only reliable metric of success.